/
Drugs for Epilepsy 16 October 2017 Drugs for Epilepsy 16 October 2017

Drugs for Epilepsy 16 October 2017 - PowerPoint Presentation

HoneyBun
HoneyBun . @HoneyBun
Follow
342 views
Uploaded On 2022-07-28

Drugs for Epilepsy 16 October 2017 - PPT Presentation

1 Epilepsy Seizure Brief episode of abnormal electrical activity in nerve cells of the brain Convulsion Involuntary spasmodic contractions of any or all voluntary muscles throughout the body including skeletal and facial muscles ID: 930794

2017 october acid seizures october 2017 seizures acid valproic drug drugs phenytoin carbamazepine gaba lamotrigine clonic partial consciousness phenobarbital

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Drugs for Epilepsy 16 October 2017" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Drugs for Epilepsy

16 October 2017

1

Slide2

Epilepsy

SeizureBrief episode of abnormal electrical activity in nerve cells of the brainConvulsionInvoluntary spasmodic contractions of any or all voluntary muscles throughout the body, including skeletal and facial muscles

EpilepsyChronic, recurrent pattern of seizures

16 October 2017

2

Slide3

Epilepsy

The third most common neurologic disorder after

cerebrovascular and Alzheimer’s disease.the

sudden, excessive

, and synchronous discharge of cerebral neurons

.

This abnormal electrical

activity may result in a variety of events, including

loss of

consciousness, abnormal movements, atypical or odd behavior, and distorted perceptions that are of limited duration but recur if untreated.

16 October 2017

3

Slide4

ETIOLOGY OF SEIZURES

Primary (idiopathic)Cause cannot be determined

More than 50% of epilepsy casesSecondary (symptomatic)

Distinct cause is identified

Trauma

, infection, cerebrovascular

disorder

Focal areas that are functionally

abnormal may be triggered

into activity by changes in

physiologic factors

, such as an alteration in blood gases, pH, electrolytes, and blood glucose and changes in environmental factors, such as sleep deficiency, alcohol intake, and stress.

16 October 2017

4

Slide5

Classification of Epilepsy

A. Focal (

Partial-onset seizures) involve only a portion of the brain, typically part

of one

lobe of one hemisphere.

The

symptoms

depend

on the site of neuronal discharge and on the extent

to which the electrical activity spreads to other neurons in the brain.

Focal seizures may progress to become generalized tonic–clonic seizures.

16 October 2017

5

Slide6

A. Focal (Partial-onset seizures)

1. Simple partial: The electrical discharge does not spread, and the patient does not lose

consciousness. The patient often exhibits abnormal activity of a single limb

or muscle group that is controlled by the region of the

brain.

Simple

partial seizures may occur

at any age.

16 October 2017

6

Slide7

A. Focal (Partial-onset seizures

)2. Complex partial:

These seizures exhibit complex sensory hallucinations and mental alteration.

Motor dysfunction may

involve chewing

movements, diarrhea, and/or urination. Consciousness is

altered.

Complex

partial seizures may occur at any age.

16 October 2017

7

Slide8

B. Generalized

May begin locally and then progress to include abnormal electrical discharges throughout both hemispheres of the brain.

It may be convulsive or nonconvulsive

, and the patient usually has

loss of consciousness

.

1. Tonic–clonic: These seizures result in loss of

consciousness, followed

by

tonic (continuous contraction) and

clonic (rapid

contraction and

relaxation

) phases. 16 October 20178

Slide9

2. Absence: involve a brief,

rapid, and selflimiting loss of consciousness. The onset generally occurs in patients at 3 to 5 years of age and lasts until puberty or beyond.

The

patient

exhibits

rapid

eye-blinking, which lasts for

3 to 5 seconds.

3. Myoclonic:

short

episodes of muscle contractions that may recur for several minutes. Myoclonic seizures occur at any age but usually begin

around puberty

or early adulthood.

16 October 20179

Slide10

4. Clonic: consist of short episodes of

muscle contractions that may closely resemble myoclonic seizures. Consciousness is more impaired with clonic seizures as compared to myoclonic.

5. Tonic: involve increased tone in the extension muscles

and are generally less than 60 seconds long.

6. Atonic:

also

known as drop attacks and

are characterized

by a sudden loss of muscle tone.

16 October 2017

10

Slide11

16 October 2017

11

Slide12

Status epilepticus

:A series of seizures (usually tonic-clonic) without recovery of consciousness between attacks; it

is a life-threatening emergency.

16 October 2017

12

Slide13

16 October 2017

13

Slide14

PHARMACOKINETICS

A. PhenytoinPhenytoin metabolism is nonlinear

; elimination kinetics shift from first-order to zero orderThe

metabolism of

phenytoin

is enhanced in the presence

of inducers

of liver metabolism (

eg, phenobarbital, rifampin) and

inhibited by other drugs (eg,

cimetidine, isoniazid

).

Phenytoin itself induces hepatic drug metabolism, decreasing the effects of other antiepileptic drugs including carbamazepine, clonazepam

, and lamotrigine.

Fosphenytoin

is a water-soluble

prodrug

form of

phenytoin that is used

parenterally

.

16 October 2017

14

Slide15

B. Carbamazepine

Carbamazepine induces formation of liver drug-metabolizing enzymes that increase metabolism of the drug itself and

may increase the clearance of many other anticonvulsant drugs including

clonazepam

,

lamotrigine

, and

valproic

acid.Carbamazepine

metabolism can be inhibited by other drugs (eg, propoxyphene,valproic

acid

). A related drug, oxcarbazepine, is less likely to be involved in drug interactions.

16 October 2017

15

Slide16

C. Valproic

AcidIn addition to competing for phenytoin plasma protein binding sites

, valproic acid inhibits the metabolism of

carbamazepine,

ethosuximide

, phenytoin, phenobarbital

, and

lamotrigine

.

Hepatic biotransformation of valproic

acid leads to formation of a

toxic metabolite

that has been

implicated in the hepatotoxicity of the drug.16 October 2017

16

Slide17

D. Other Drugs

Gabapentin, pregabalin, levetiracetam, and

vigabatrinEliminated

by the kidney, largely in

unchanged form

.

These

agents have virtually no drug-drug interactions.

Tiagabine

, topiramate

, and zonisamide undergo both hepatic metabolism

and renal elimination of intact drug

.

Lamotrigine is eliminated via hepatic glucuronidation.

16 October 2017

17

Slide18

MECHANISMS OF ACTION

Effect of antiseizure drugs is to suppress repetitive

action potentials in epileptic foci in the brain. A. Sodium Channel Blockade

Phenytoin

,

carbamazepine,

lamotrigine

, and

zonisamide

block voltage-gated sodium channels in

neuronal membranes

.

results in prolongation of the inactivated state of the Na+ channel and the refractory period of the neuron. Phenobarbital and valproic

acid may exert similar effects at high doses.

16 October 2017

18

Slide19

B. GABA-Related Targets

Benzodiazepines interact with specific receptors on the GABAA receptor–chloride ion channel (facilitate the inhibitory

effects of GABA).

Phenobarbital

also

enhance the inhibitory actions of GABA but interact with

a different receptor site on chloride ion channels that results in

an increased

duration of chloride ion channel opening.

16 October 2017

19

Slide20

B. GABA-Related Targets

GABA aminotransaminase

(GABA-T) is an enzyme in the termination of action of GABA. The enzyme is

irreversibly inactivated

by

vigabatrin

and can also

be inhibited by

valproic

acid.

Tiagabine inhibits a GABA transporter (GAT-1) in neurons

and glia

prolonging the action of the neurotransmitter.

Gabapentin is GABA analog, but it does not activate GABA receptors directly.

Felbamate

,

topiramate

, and

valproic

acid

facilitate

the inhibitory

actions of

GABA

.

16 October 2017

20

Slide21

C. Calcium Channel Blockade

Ethosuximide inhibits low-threshold (T type) Ca2+

currents , especially in thalamic neurons.A

similar action is reported for

valproic

acid

, as well as for both

gabapentin

and

pregabalin.

D. Other mechanismsvalproic

acid

causes neuronal membrane hyperpolarization

, possibly by enhancing K+ channel permeability. Phenobarbital , Topiramate, and

Felbamate acts as an antagonist

at

glutamate NMDA

receptors.

16 October 2017

21

Slide22

CLINICAL USES

Up to 80% of patients can expect partial or complete control of seizures with appropriate treatment.

Antiepileptic drugs suppress but do not cure

or prevent

seizures

Antiepileptics

are indicated when there is two or more seizures occurred in short interval (6m -1 y)

An initial therapeutic aim is to use only one drug (

monotherapy)

16 October 2017

22

Slide23

A. Generalized Tonic-Clonic

SeizuresValproic acid, carbamazepine, and phenytoin

are the drugs of choice for generalized tonic-clonic (grand mal) seizures.

Phenobarbital

(

or

primidone

) is now considered to be an alternative agent in

adults but continues to be a primary drug in infants.

Lamotrigine and

topiramate

are also approved drugs for this indication.16 October 2017

23

Slide24

B. Partial SeizuresThe drugs of first choice are

carbamazepine (or oxcarbazepine) or lamotrigine or

phenytoin. Alternatives include

felbamate

,

topiramate

,

phenobarbital

, and

valproic acid.

Many

of the

newer anticonvulsants can be used adjunctively including gabapentin and pregabalin, a structural congener.

16 October 2017

24

Slide25

C. Absence Seizures

Ethosuximide or valproic acid are the preferred drugs because they cause minimal sedation.

Valproic

acid

is particularly useful

in patients who have concomitant generalized tonic-

clonic

or myoclonic seizures. Clonazepam

is an alternative drug (disadvantages sedation and

tolerance).

Lamotrigine

, levetiracetam, and zonisamide are also effective in absence seizures.

16 October 2017

25

Slide26

D. Status Epilepticus

I.V diazepam or lorazepam

is usually effective providing short-term control. For prolonged therapy

,

I.V

phenytoin

(highly

effective and less

sedating).

Phenytoin may cause

cardiotoxicity, and

fosphenytoin

(

water soluble) is a safer parenteral agent. Phenobarbital used in status epilepticus

, especially in children.

In

very

severe status

epilepticus

that does not respond to these measures,

general anesthesia

may be used.

16 October 2017

26

Slide27

E. Other Clinical Uses

Valproic acid is used as a first-line drug in the treatment of mania.

Carbamazepine and lamotrigine have also been used successfully in

bipolar disorder

.

Carbamazepine

is the drug of choice for

trigeminal

neuralgia

.

Gabapentin and Pregabalin have efficacy in pain

of neuropathic

origin, including

postherpetic neuralgia, and, like phenytoin, may have some value in migraine.

Topiramate

is

also used

in the treatment of

migraine

.

16 October 2017

27

Slide28

TOXICITY:

A. Teratogenicity ; congenital malformations. Neural tube defects (eg,

spina bifida) are associated with the use of valproic

acid

.

carbamazepine

has been implicated as a cause of

craniofacial anomalies

and spina

bifida.A fetal

hydantoin

syndrome

has been described after phenytoin use by pregnant women, also Gingival hyperplasia.

16 October 2017

28

Slide29

B. Overdosage

ToxicityMost of the commonly used anticonvulsants are CNS depressants, and

respiratory depression may occur with overdosage. Management is

primarily supportive (airway management, mechanical ventilation

), and

flumazenil

may be used in benzodiazepine overdose.

16 October 2017

29

Slide30

C. Life-Threatening Toxicity

Fatal hepatotoxicity with valproic acid (risk

to children younger than 2 years and patients taking multiple anticonvulsant drugs).

Lamotrigine

has caused skin rashes

and life-threatening Stevens-Johnson syndrome

or

toxic

epidermal necrolysis. Children are at higher risk (1–2% incidence),

especially if they are also taking valproic

acid

.

Reports of aplastic anemia and acute hepatic failure have limited the use of

felbamate to severe, refractory seizure states.

16 October 2017

30